Concepedia

Intrathyroidal epithelial thymoma (ITET)/carcinoma showing thymus‐like differentiation (CASTLE) exhibits CD5 immunoreactivity: new evidence for thymic differentiation

DORFMAN DORFMAN, Shahsafaei, Miyauchi

Histopathology · 1998 · 98 citations · 11 references

DOI

Abstract

CD5 immunoreactivity in ITET/CASTLE is new evidence in support of thymic differentiation in this neoplasm.

References

11

Depletion of CD4 <sup>+</sup> T Cells in Major Histocompatibility Complex Class II-Deficient Mice

Michael J. Grusby, Randall S. Johnson, Virginia E. Papaioannou et al. · Science · 1991 · 661 citations

The B-cell surface protein CD72/Lyb-2 is the ligand for CDS

H. Van de Velde, Ilka von Hoegen, Wei Luo et al. · Nature · 1991 · 298 citations

, , +5

Intrathyroidal epithelial thymoma: An entity distinct from squamous cell carcinoma of the thyroid

Akira Miyauchi, Kanji Kuma, Fumio Matsuzuka et al. · World Journal of Surgery · 1985 · 200 citations

Thymic carcinomas, but not thymomas and carcinomas of other sites, show CD5 immunoreactivity.

David Dorfman, Aliakbar Shahsafaei, John Chan · The American Journal of Surgical Pathology · 1997 · 146 citations

CD5 expression in thymic carcinoma.

Tsunekazu Hishima, Masashi Fukayama, M. Fujisawa et al. · PubMed · 1994 · 135 citations · Full text